Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche posts interim TIGIT overall survival data after 'inadvertent disclosure,' sending stocks up
Fierce Biotech
Wed, 08/23/23 - 10:10 am
Tags:
Roche, Tigit, clinical trials, lung cancer, non-small cell lung cancer, tiragolumab
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown
Fierce Pharma
Mon, 08/21/23 - 10:43 am
Tags:
Merck, Roche, pharma sales, Keytruda
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
Tags:
clinical trials, Sarepta Therapeutics, DMD, Elevidys, Bridge Bio, ATTR-CM, acoramidis, Sanofi, Merck KGaA, MS, tolebrutinib, Pfizer, obesity, danuglipron, Novo Nordisk, Ozempic, Verve Therapeutics, heterozygous familial hypercholesterolemia, Roche, lung cancer, tiragolumab, Vertex Pharmaceutical, VS-548, pain, JNJ, Bristol Myers Squibb
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Mon, 08/7/23 - 10:14 am
Tags:
Daiichi Sankyo, antibody drug conjugate, oncology, Seagen, Roche
Filings signal: Despite Covid losses, pharma earnings are promising
Clinical Trials Arena
Wed, 08/2/23 - 11:32 am
Tags:
Takeda, AstraZeneca, Roche, earnings, COVID-19
Phase III trial results bring subcutaneous Ocrevus closer to its potential approval
Clinical Trials Arena
Mon, 07/31/23 - 10:09 am
Tags:
Roche, Ocrevus, clinical trials, MS, multiple sclerosis
Roche Drops Hemophilia A Candidate, Prepares for the Impacts of IRA
BioSpace
Thu, 07/27/23 - 11:36 am
Tags:
Roche, RG6358, Spark Therapeutics, hemophilia A, earnings
Roche Decides Not to Exercise Solid Tumor Option with SQZ
BioSpace
Tue, 07/25/23 - 08:50 pm
Tags:
Roche, solid tumors, SQZ Biotech
Roche, Alnylam Ink Potential $2.8B RNAi Partnership for Hypertension
BioSpace
Mon, 07/24/23 - 11:29 am
Tags:
Roche, Alnylam, RNAi, hypertension, zilebesiran
Roche’s Vabysmo reports positive outcomes in multiple eye diseases
Clinical Trials Arena
Thu, 07/20/23 - 10:04 am
Tags:
Roche, Vabysmo, diabetic macular edema, wet age-related macular degeneration
Scratching the surface of the urticaria pipeline
EP Vantage
Thu, 07/20/23 - 10:00 am
Tags:
chronic urticaria, Sanofi, Dupixent, Regeneron, Novartis, Roche, Xolair, Allakos, AstraZeneca, Celldex Therapeutics
Roche, mirroring Novartis, guilty of most serious marketing breach for Polivy website
Fierce Pharma
Mon, 07/17/23 - 08:44 am
Tags:
Roche, PMCPA, pharma marketing, Polivy
Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report
BioSpace
Fri, 07/14/23 - 11:56 am
Tags:
Roche, Roivant, ulcerative colitis, Crohn's Disease, M&A
Roche finds USP in cancer, inking deal with KSQ to expand stable of synthetic lethal candidates
Fierce Biotech
Thu, 07/13/23 - 11:36 am
Tags:
Roche, KSQ Therapeutics, synthetic lethality
Roche eyes alternate mode of administration for Ocrevus in MS
Clinical Trials Arena
Thu, 07/13/23 - 10:21 am
Tags:
Roche, Ocrevus, clinical trials, MS, multiple sclerosis
Global trade group taps Pfizer, Roche and Daiichi execs for 2-year stints on CEO leadership team
Fierce Pharma
Wed, 07/12/23 - 11:08 pm
Tags:
IFPMA, Pfizer, Albert Bourla, Roche, Thomas Schinecker
Roche pulls a Gavreto approval before Blueprint severance, citing unfeasible trial
Fierce Pharma
Wed, 07/5/23 - 07:12 pm
Tags:
Roche, Blueprint Medicines, cancer, Gavreto, accelerated approvals, FDA
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
Tags:
FDA, Eisai, Biogen, Leqembi, Alzheimer's disease, SAGE Therapeutics, zuranolone, postpartum depression, major depressive disorder, Roche, Tecentriq, non-small cell lung cancer, CRISPR Therapeutics, Bluebird Bio, lovo-cel, exa-cel, BrainStorm Cell Therapeutics, NurOwn
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
Tags:
AbbVie, Genmab, Roche, follicular lymphoma, bispecific antibodies, epcoritamab, Lunsumio
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
Tags:
FDA, clinical trials, Sarepta Therapeutics, Bridge Bio, Sanofi, Merck KGaA, Pfizer, Novo Nordisk, Verve Therapeutics, Roche, Vertex Pharmaceuticals, JNJ, Bristol Myers Squibb, ATTR-CM, Elevidys, tolebrutinib, evobrutinib, danuglipron, tiragolumab, VX-548, lazertinib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.